413 related articles for article (PubMed ID: 10858976)
1. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G
J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta is involved in the pathogenesis of dialysis-related amyloidosis.
Matsuo K; Ikizler TA; Hoover RL; Nakamoto M; Yasunaga C; Pupim LB; Hakim RM
Kidney Int; 2000 Feb; 57(2):697-708. PubMed ID: 10652049
[TBL] [Abstract][Full Text] [Related]
3. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1.
Miyata T; Inagi R; Iida Y; Sato M; Yamada N; Oda O; Maeda K; Seo H
J Clin Invest; 1994 Feb; 93(2):521-8. PubMed ID: 8113390
[TBL] [Abstract][Full Text] [Related]
4. Impaired lysosomal processing of beta2-microglobulin by infiltrating macrophages in dialysis amyloidosis.
García-García M; Argilés ; Gouin-Charnet A; Durfort M; García-Valero J; Mourad G
Kidney Int; 1999 Mar; 55(3):899-906. PubMed ID: 10027926
[TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous ambulatory peritoneal dialysis.
Rashid G; Korzets Z; Bernheim J
Isr Med Assoc J; 2006 Jan; 8(1):36-9. PubMed ID: 16450750
[TBL] [Abstract][Full Text] [Related]
6. beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.
Miyata T; Oda O; Inagi R; Iida Y; Araki N; Yamada N; Horiuchi S; Taniguchi N; Maeda K; Kinoshita T
J Clin Invest; 1993 Sep; 92(3):1243-52. PubMed ID: 8376584
[TBL] [Abstract][Full Text] [Related]
7. Amyloid beta 2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis.
Niwa T; Katsuzaki T; Miyazaki S; Momoi T; Akiba T; Miyazaki T; Nokura K; Hayase F; Tatemichi N; Takei Y
Kidney Int; 1997 Jan; 51(1):187-94. PubMed ID: 8995733
[TBL] [Abstract][Full Text] [Related]
8. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis.
Miyata T; Hori O; Zhang J; Yan SD; Ferran L; Iida Y; Schmidt AM
J Clin Invest; 1996 Sep; 98(5):1088-94. PubMed ID: 8787669
[TBL] [Abstract][Full Text] [Related]
9. New aspects in the pathogenesis of dialysis-related amyloidosis: pathophysiology of advanced glycation end products in renal failure.
Miyata T
Nihon Jinzo Gakkai Shi; 1996 May; 38(5):191-7. PubMed ID: 8699608
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end product-modified beta2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosis.
Fujimoto N; Yajima M; Ohnishi Y; Tajima S; Ishibashi A; Hata Y; Enomoto U; Konohana I; Wachi H; Seyama Y
J Invest Dermatol; 2002 Mar; 118(3):479-84. PubMed ID: 11874487
[TBL] [Abstract][Full Text] [Related]
11. Dialysis-related amyloidosis of the heart in long-term hemodialysis patients.
Takayama F; Miyazaki S; Morita T; Hirasawa Y; Niwa T
Kidney Int Suppl; 2001 Feb; 78():S172-6. PubMed ID: 11169005
[TBL] [Abstract][Full Text] [Related]
12. Dialysis-related amyloidosis: late finding or hidden epidemic?
Dember LM; Jaber BL
Semin Dial; 2006; 19(2):105-9. PubMed ID: 16551286
[TBL] [Abstract][Full Text] [Related]
13. Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosis.
Giorgetti S; Stoppini M; Tennent GA; Relini A; Marchese L; Raimondi S; Monti M; Marini S; Østergaard O; Heegaard NH; Pucci P; Esposito G; Merlini G; Bellotti V
Protein Sci; 2007 Feb; 16(2):343-9. PubMed ID: 17242436
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous and lingual papules as a sign of beta 2 microglobulin-derived amyloidosis in a long-term hemodialysis patient.
Uenotsuchi T; Imafuku S; Nagata M; Kiryu H; Morita K; Koga T; Furue M
Eur J Dermatol; 2003; 13(4):393-5. PubMed ID: 12948922
[TBL] [Abstract][Full Text] [Related]
15. Electron microscopic characteristics of beta2-microglobulin amyloid deposits in long-term haemodialysis.
Bély M; Kapp P; Szabó TS; Lakatos T; Apáthy A
Ultrastruct Pathol; 2005; 29(6):483-91. PubMed ID: 16316949
[TBL] [Abstract][Full Text] [Related]
16. A beta2-microglobulin cleavage variant fibrillates at near-physiological pH.
Corlin DB; Johnsen CK; Nissen MH; Heegaard NH
Biochem Biophys Res Commun; 2009 Apr; 381(2):187-91. PubMed ID: 19232323
[TBL] [Abstract][Full Text] [Related]
17. beta2-microglobulin-derived amyloidosis: an update.
Floege J; Ketteler M
Kidney Int Suppl; 2001 Feb; 78():S164-71. PubMed ID: 11169004
[TBL] [Abstract][Full Text] [Related]
18. N epsilon-(carboxymethyl)lysine in blood from maintenance hemodialysis patients may contribute to dialysis-related amyloidosis.
Motomiya Y; Oyama N; Iwamoto H; Uchimura T; Maruyama I
Kidney Int; 1998 Oct; 54(4):1357-66. PubMed ID: 9767556
[TBL] [Abstract][Full Text] [Related]
19. Glycosaminoglycans enhance the fibrillation propensity of the β2-microglobulin cleavage variant--ΔK58-β2m.
Corlin DB; Johnsen CK; Nissen MH; Heegaard NH
Biochem Biophys Res Commun; 2010 Nov; 402(2):247-51. PubMed ID: 20939999
[TBL] [Abstract][Full Text] [Related]
20. Beta2-microglobulin and renal bone disease.
Wada T; Miyata T; Sakai H; Kurokawa K
Perit Dial Int; 1999; 19 Suppl 2():S413-6. PubMed ID: 10406556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
